-
Loading metrics
NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma
- Patricia C Galipeau,
- Xiaohong Li,
- Patricia L Blount,
- Carlo C Maley,
- Carissa A Sanchez,
- Robert D Odze,
- Kamran Ayub,
- Peter S Rabinovitch,
- Thomas L Vaughan,
- Brian J Reid
x
- Published: February 27, 2007
- https://doi.org/10.1371/journal.pmed.0040067